2021
DOI: 10.1016/j.ab.2020.113744
|View full text |Cite
|
Sign up to set email alerts
|

Refining our methodologies for assessing quadruplex DNA ligands; selectivity or an illusion of selectivity?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
2
1

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 46 publications
0
2
0
Order By: Relevance
“…Nonetheless, G4-disruptive small molecules have significant therapeutic potential, as highlighted recently by Monchaud et al, across diseases with their origins in helicase impairment, including in a number of genetic and neurological disorders . Design of small molecules that can both probe and disrupt G4 structures offers an elusive but desirable therapeutic prospect . Indeed, one of the most compelling ways to confirm the G4 presence in vivo is by direct visualization, e.g., through fluorescence imaging.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Nonetheless, G4-disruptive small molecules have significant therapeutic potential, as highlighted recently by Monchaud et al, across diseases with their origins in helicase impairment, including in a number of genetic and neurological disorders . Design of small molecules that can both probe and disrupt G4 structures offers an elusive but desirable therapeutic prospect . Indeed, one of the most compelling ways to confirm the G4 presence in vivo is by direct visualization, e.g., through fluorescence imaging.…”
Section: Introductionmentioning
confidence: 99%
“… 38 Design of small molecules that can both probe and disrupt G4 structures offers an elusive but desirable therapeutic prospect. 39 Indeed, one of the most compelling ways to confirm the G4 presence in vivo is by direct visualization, e.g., through fluorescence imaging. The earliest imaging-based evidence for in cellulo G4 originated from fixed cell studies using labeled antibodies toward G4.…”
Section: Introductionmentioning
confidence: 99%